Edaravone Dexborneol tablet for stroke recovery
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests a new sublingual tablet (Edaravone Dexborneol) to help people recover after a small stroke caused by disease of the small blood vessels in the brain. It aims to see if the drug can improve thinking and daily function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 30 and 80 years old.
- You had a small stroke in the deep brain areas confirmed by MRI.
- Your stroke started less than 3 weeks ago.
- You had little or no disability before the stroke (able to do daily activities independently).
- You have no previous diagnosis of dementia or cognitive problems.
- You are able to complete thinking and memory tests (at least primary school education).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new approach for treating acute ischemic stroke within 4.5 hours of symptoms starting. It combines a special mobile stroke unit that delivers early brain-protecting medicine with standard clot-busting or clot-removal procedures, to see if this can improve recovery.
This trial tests a new medication (bevifibatide) to see which dose works best for people having an ischemic stroke who cannot get standard treatments like clot-busting drugs or a procedure to remove the clot. It aims to improve recovery by stopping clots from getting worse.
This trial tests a new medicine called SP-8203 added to standard clot-busting treatment for people having a moderate to severe stroke. The goal is to see if it helps improve recovery and is safe.
This study tests an experimental drug called ALT001 for people who are still recovering from a stroke that happened at least 6 months ago and within the last 5 years. The drug may help improve limb weakness that persists after a stroke.
This study tests an under-the-tongue tablet (edaravone dexborneol) to help thinking and memory problems that can happen after an ischemic stroke. It may help people who recently had a stroke and now have trouble with attention, memory, or planning.
This trial tests a medicine called edaravone dexborneol to see if it helps people recover from a recent ischemic stroke (a stroke caused by a blocked blood vessel). The medicine is given within 48 hours of the stroke, and the study will compare how well it works and if it is safe.
Hear when a new Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.